Maravai Lifesciences Earnings Estimate
| MRVI Stock | USD 5.93 0.50 9.21% |
Maravai Lifesciences Revenue Breakdown by Earning Segment
By analyzing Maravai Lifesciences' earnings estimates, investors can diagnose different trends across Maravai Lifesciences' analyst sentiment over time as well as compare current estimates against different timeframes. As of now, Maravai Lifesciences' Pretax Profit Margin is increasing as compared to previous years. The Maravai Lifesciences' current Gross Profit Margin is estimated to increase to 0.52, while Gross Profit is projected to decrease to under 133.2 M.
Maravai |
Maravai Lifesciences Earnings Estimation Breakdown
The calculation of Maravai Lifesciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Maravai Lifesciences is estimated to be -0.02045 with the future projection ranging from a low of -0.025 to a high of -0.015. Please be aware that this consensus of annual earnings estimates for Maravai Lifesciences Holdings is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.03 Lowest | Expected EPS | -0.01 Highest |
Maravai Lifesciences Earnings Projection Consensus
Suppose the current estimates of Maravai Lifesciences' value are higher than the current market price of the Maravai Lifesciences stock. In this case, investors may conclude that Maravai Lifesciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Maravai Lifesciences' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 15 | 40.19% | -0.02 | -0.02045 | -1.67 |
Maravai Lifesciences Earnings History
Earnings estimate consensus by Maravai Lifesciences analysts from Wall Street is used by the market to judge Maravai Lifesciences' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Maravai Lifesciences' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Maravai Lifesciences Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Maravai Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Maravai Lifesciences Earnings per Share Projection vs Actual
Actual Earning per Share of Maravai Lifesciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Maravai Lifesciences Holdings predict the company's earnings will be in the future. The higher the earnings per share of Maravai Lifesciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Maravai Lifesciences Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Maravai Lifesciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Maravai Lifesciences should always be considered in relation to other companies to make a more educated investment decision.Maravai Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Maravai Lifesciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-05-23 | 2025-03-31 | -0.02 | -0.02 | 0.0 | 0 | ||
2024-11-07 | 2024-09-30 | -0.01 | -0.02 | -0.01 | 100 | ||
2024-08-07 | 2024-06-30 | -0.0008 | -0.0558 | -0.055 | 6875 | ||
2024-05-08 | 2024-03-31 | -0.03 | -0.02 | 0.01 | 33 | ||
2024-02-22 | 2023-12-31 | -0.01 | 0.01 | 0.02 | 200 | ||
2023-11-07 | 2023-09-30 | 0.01 | -0.01 | -0.02 | 200 | ||
2023-08-07 | 2023-06-30 | 0.01 | -0.05 | -0.06 | 600 | ||
2023-05-08 | 2023-03-31 | 0.04 | 0.03 | -0.01 | 25 | ||
2023-02-22 | 2022-12-31 | 0.34 | 0.35 | 0.01 | 2 | ||
2022-11-02 | 2022-09-30 | 0.33 | 0.37 | 0.04 | 12 | ||
2022-08-04 | 2022-06-30 | 0.45 | 0.54 | 0.09 | 20 | ||
2022-05-05 | 2022-03-31 | 0.44 | 0.54 | 0.1 | 22 | ||
2022-02-23 | 2021-12-31 | 0.38 | 0.45 | 0.07 | 18 | ||
2021-11-10 | 2021-09-30 | 0.35 | 0.44 | 0.09 | 25 | ||
2021-08-10 | 2021-06-30 | 0.32 | 0.44 | 0.12 | 37 | ||
2021-05-10 | 2021-03-31 | 0.21 | 0.26 | 0.05 | 23 | ||
2021-03-02 | 2020-12-31 | 0.11 | 0.13 | 0.02 | 18 |
About Maravai Lifesciences Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Maravai Lifesciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Maravai Lifesciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Maravai Lifesciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | 285.7 M | 145.8 M | |
| Retained Earnings Total Equity | 166.1 M | 147.6 M | |
| Earnings Yield | (0.14) | (0.13) | |
| Price Earnings Ratio | (7.26) | (7.62) | |
| Price Earnings To Growth Ratio | 0.06 | 0.06 |
Currently Active Assets on Macroaxis
When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (1.67) | Revenue Per Share 2.044 | Quarterly Revenue Growth (0.03) | Return On Assets (0.02) |
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.